28 Ago 2024
Prevention and management of radiotherapy‑related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)
Visualizza Documento
12 Ott 2023
Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: A study by the Italian association of radiotherapy and clinical oncology (AIRO)
Visualizza Documento
29 Set 2023
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1)
Visualizza Documento
24 Mag 2023
“Survey sulle Conoscenze e Atteggiamenti relativi all’Utilizzo della Radioterapia Stereotassica nella Gestione del Tumore ovarico oligometastatico/persistente/ricorrente (MPR-OC) in Trattamento con PARP-Inibitori” – deadline 15-07-2023
Lettera di invito alla compilazione Link per la Compilazione della Survey
EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC UTERINE CANCER (MITO-RT2/RAD STUDY): A LARGE, REAL-WORLD STUDY IN COLLABORATION WITH AIRO GYN, MITO and MaNGO Groups
Visualizza Documento
12 Nov 2022
Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups
Visualizza Documento
8 Giu 2022
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups
Visualizza Documento
